adminの記事一覧

Renoprotective effect of the xanthine oxidoreductase inhibitor, Topiroxostat,on Adenine-Induced Renal Injury.

Am J Physiol Renal Physiol. 310(11):F1366-1376, 2016.PubMed

Novel urinary tubular injury markers reveal an evidence of underlying kidney injury in children with reduced left ventricular systolic function: a pilot study.

Pediatr Nephrol. 2016.PubMed

Clinical utility of urinary liver-type fatty acid binding protein measured by latex-enhanced turbidimetric immunoassay in chronic kidney disease.

Clin Chem Lab Med. 2016.PubMed

Urinary L-FABP as a mortality predictor among < 5 septic children in Bangladesh.

Pediatr Int. 185-191, 2016.PubMed

Clinical significance of urinary liver-type fatty acid-binding protein as a predictor of ESRD and CVD in patients with CKD.

Clin Exp Nephrol. 20(2): 195-203, 2016.PubMed

Urinary markers in the early stage of nephropathy in patients with childhood-onset type 1 diabetes.

Pediatr Nephrol. 31(4):623-631, 2016.PubMed

Follow-Up Renal Assessment of Injury Long-Term After Acute Kidney Injury (FRAIL-AKI).

Clin J Am Soc Nephrol. 11(1):21-29, 2015.PubMed

Clinical usefulness of urinary liver-type fatty-acid-binding protein as a perioperative marker of acute kidney injury in patients undergoing endovascular or open-abdominal aortic aneurysm repair.

J Anesth. 30(1): 89-99. 2015.PubMed

Epoetin beta pegol alleviates oxidative stress and exacerbation of renal damage from iron deposition, thereby delaying CKD progression in progressive glomerulonephritis rats.

Physiol Rep. 3(12), 2015.PubMed

Urinary liver-type fatty acid-binding protein change in gestational diabetes mellitus.

Diabetes Res Clin Pract. 109(3): e36-e38, 2015.PubMed